This document provides guidance on making decisions about HIV treatment. It emphasizes the importance of choosing an experienced doctor, developing a relationship with that doctor, and getting informed about HIV and treatment options. It recommends learning about HIV and options before treatment is needed in order to make informed decisions. Sources like Project Inform can provide objective information to help with the decision-making process.
This document discusses building cooperative relationships between patients and doctors in treating HIV/AIDS. It emphasizes that patients should take an active role in their healthcare by learning about their condition, preparing for appointments, and openly communicating their needs and viewpoints to their doctor. Doctors are encouraged to support their patients' interests, be flexible in their responses, and describe multiple perspectives on issues to establish trust and shared decision making. The document provides tips for both parties on how to handle disagreements respectfully.
Let's role play delivering a positive HIV test result. I'll be the provider and you be the patient. After we role play, we can discuss how it went.
Provider: Okay, I have your test results back. Please have a seat so we can discuss them. *patient sits down looking nervous* I want you to know that receiving any medical test result can be difficult to hear. Your HIV test from last week unfortunately came back positive. What are your initial thoughts or feelings about this news?
Patient: *looks shocked and upset* Oh no, I can't believe this. What does this mean for my health? Am I going to get AIDS?
Provider: I understand this is very difficult to hear
Liveworld pharma social media recommendations covid19 - enSebnem Ozdemir
The document provides guidance for pharmaceutical companies on managing their social media activities during the coronavirus crisis. It recommends that companies continue providing support to patient communities online but stop directly promoting products. It outlines specific types of content that should continue or stop for branded product pages, unbranded condition pages, and corporate pages. It also provides best practices for moderating discussions and responding to common questions from patients during this time.
This document discusses concepts related to disease screening and HIV testing models. It provides an overview of screening criteria and benefits and potential adverse effects. Voluntary counseling and testing (VCT) is described as an active case finding strategy and entry point to HIV care. Key aspects of VCT include pre-test counseling to assess risk and provide information, post-test counseling that depends on results, and the overall goal of helping clients gain knowledge and adopt protective behaviors. Special populations for VCT and various service delivery settings are also reviewed.
A breakdown of an in-house meeting around the issues surrounding the many aspects of HIV Treatment and Prevention and questions needing to be answered in dealing with it.
At the end of the session patient/family champions as well as health authorities will leave armed with best practices, resources and ideas on how to open the door for patient/family engagement with health authorities and how to make the most of the time together.
This document discusses the importance of doctors spending adequate time with patients. It notes that while appointment lengths have increased slightly in recent decades, many patients still feel their needs are not fully addressed in short consultations. The document recommends expanding appointment times to improve patient health outcomes and satisfaction in several ways. First, longer visits allow doctors to provide more preventive care advice, screenings, and health education. Second, they enable doctors to fully understand patients' health concerns and priorities through active listening. Third, preventive care and lifestyle counseling can help avert future acute illnesses and costly medical interventions. The document argues expanded appointment times offer medical, financial, and strategic benefits for healthcare practices.
Voluntry councelling and testing by dr munawar khanDr Munawar Khan
Voluntary Counseling and Testing (VCT) involves providing counseling to individuals to assess their HIV risk, discuss testing and developing a risk reduction plan, and provides testing to help people learn their HIV status so they can receive medical care and support services if needed, though many people face barriers to testing like fear, stigma, and lack of perceived benefits.
This document discusses building cooperative relationships between patients and doctors in treating HIV/AIDS. It emphasizes that patients should take an active role in their healthcare by learning about their condition, preparing for appointments, and openly communicating their needs and viewpoints to their doctor. Doctors are encouraged to support their patients' interests, be flexible in their responses, and describe multiple perspectives on issues to establish trust and shared decision making. The document provides tips for both parties on how to handle disagreements respectfully.
Let's role play delivering a positive HIV test result. I'll be the provider and you be the patient. After we role play, we can discuss how it went.
Provider: Okay, I have your test results back. Please have a seat so we can discuss them. *patient sits down looking nervous* I want you to know that receiving any medical test result can be difficult to hear. Your HIV test from last week unfortunately came back positive. What are your initial thoughts or feelings about this news?
Patient: *looks shocked and upset* Oh no, I can't believe this. What does this mean for my health? Am I going to get AIDS?
Provider: I understand this is very difficult to hear
Liveworld pharma social media recommendations covid19 - enSebnem Ozdemir
The document provides guidance for pharmaceutical companies on managing their social media activities during the coronavirus crisis. It recommends that companies continue providing support to patient communities online but stop directly promoting products. It outlines specific types of content that should continue or stop for branded product pages, unbranded condition pages, and corporate pages. It also provides best practices for moderating discussions and responding to common questions from patients during this time.
This document discusses concepts related to disease screening and HIV testing models. It provides an overview of screening criteria and benefits and potential adverse effects. Voluntary counseling and testing (VCT) is described as an active case finding strategy and entry point to HIV care. Key aspects of VCT include pre-test counseling to assess risk and provide information, post-test counseling that depends on results, and the overall goal of helping clients gain knowledge and adopt protective behaviors. Special populations for VCT and various service delivery settings are also reviewed.
A breakdown of an in-house meeting around the issues surrounding the many aspects of HIV Treatment and Prevention and questions needing to be answered in dealing with it.
At the end of the session patient/family champions as well as health authorities will leave armed with best practices, resources and ideas on how to open the door for patient/family engagement with health authorities and how to make the most of the time together.
This document discusses the importance of doctors spending adequate time with patients. It notes that while appointment lengths have increased slightly in recent decades, many patients still feel their needs are not fully addressed in short consultations. The document recommends expanding appointment times to improve patient health outcomes and satisfaction in several ways. First, longer visits allow doctors to provide more preventive care advice, screenings, and health education. Second, they enable doctors to fully understand patients' health concerns and priorities through active listening. Third, preventive care and lifestyle counseling can help avert future acute illnesses and costly medical interventions. The document argues expanded appointment times offer medical, financial, and strategic benefits for healthcare practices.
Voluntry councelling and testing by dr munawar khanDr Munawar Khan
Voluntary Counseling and Testing (VCT) involves providing counseling to individuals to assess their HIV risk, discuss testing and developing a risk reduction plan, and provides testing to help people learn their HIV status so they can receive medical care and support services if needed, though many people face barriers to testing like fear, stigma, and lack of perceived benefits.
At the end of the session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to advance patient engagement in medication safety as a result of their increased understanding of:
. the role and responsibilities of patients/ families in medication safety
. different approaches to patient engagement in medication safety
. influencing factors (e.g. health literacy, culture, organizational and public policy)
. supporting resources and leading practices
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...iCAADEvents
There is little and con icting evidence on the prevalence of alcohol misuse and treatment available for people with Intellectual Disabilities (also referred as Learning Disabilities). As is similar to other vulnerable populations, adults with ID have increasingly lived more independently in the community following the closure of long-stay hospitals. This has increased their exposure to environmental stressors and substance and alcohol misuse, negatively impacting on their functioning, relationships, physical and mental health, and safety. Traumatic Brain Injury (TBI) is the most common cause of disability in younger adults. Yet the community care for patients with TBI varies hugely in the UK. There is a well-established link between TBI and alcohol misuse, with both TBI leading to increased levels of alcohol misuse and alcohol misuse contributing to risk of TBIs. The effects of neuronal damage have been shown to increase after TBI accompanied by alcohol intoxication.This presentation is based on the experience gained from the rst in the UK feasibility study on this topic, and draws from the experience of setting up and running the first ever pilot of a combined TBI and alcohol brief intervention service in London.
The document discusses using social media to understand patient journeys and identify opportunities to educate patients about a rheumatoid arthritis treatment called Product R. It describes analyzing social media posts to develop themes around patient barriers, milestones, and information needs at different stages, including treatment initiation, managing the condition, and becoming engaged in treatment. The analysis revealed opportunities to provide educational resources on side effects, problem solving strategies, and tools to facilitate patient-doctor communication.
This document summarizes a presentation on technologies to reduce prescription drug diversion, fraud, and abuse through electronic prescribing and drug deactivation systems. It discusses Delaware's pilot program with an at-home drug deactivation system. The presentation describes how electronic prescribing of controlled substances can reduce diversion and fraud while improving patient satisfaction. It also outlines DEA requirements for electronic prescribing and discusses Cambridge Health Alliance's experience implementing electronic prescribing of controlled substances with Epic and Imprivata. Finally, it summarizes the results of Delaware's pilot program, which provided at-home drug deactivation systems to specific pharmacies to promote safe disposal of unused prescription drugs.
How useful are advance directives in directing end of life care and do people really understand or want to know the true status of their health as the end nears?
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranOPUNITE
This document summarizes a presentation on a study examining how prescriber registration and use of a prescription drug monitoring program (PDMP) in Oregon impacted opioid prescribing patterns and patient outcomes. The study found that statewide opioid prescribing generally decreased over time, but prescribers who registered for the PDMP prescribed more after registering, especially those who used the PDMP most frequently. In contrast, prescribers who did not register prescribed less. Patients whose providers were all registered had lower overdose rates than those with some registered and some non-registered providers. The conclusions were that PDMPs may need refinements like mandatory use to optimize their impact on prescribing and outcomes.
The document discusses the Personal Health Record (PHR), which allows individuals to manage their own health information in order to better participate in their healthcare. A PHR contains health history, medications, allergies, immunizations and other medical data from individuals and providers. PHRs provide benefits like increased patient involvement, but also have barriers like usability, privacy and reliability concerns. The selection of a secure and standards-based PHR is important for managing personal health information.
Va open notes and blue button va ehealth university dec 2012Susan Woods
This document discusses the VA's Blue Button and Open Notes initiatives which aim to give patients access to their health records and information. It notes that over 1.9 million VA patients have registered for online access to their records through My HealtheVet. The document outlines what health data is currently available to patients through the VA's patient portal as well as what additional data may be made available in the future. It discusses the benefits of open notes and greater patient access to health records based on studies that have found it improves patient-provider communication, patient knowledge and self-care, and patient participation in their care. The document advocates for continued expansion of patient access to health records and greater patient involvement in healthcare design and delivery.
Nothing in our world is changing as quickly as healthcare. Patients are using search, social media and apps to diagnose symptoms, research physicians, schedule appointments, access medical records, connect with other patients and take a more active role in their health. At the same time the tremendous amount of data created by this activity means patients have a much larger digital footprint than ever before. Savvy healthcare marketers can use this data to attract new patients, improve care and collaborate with other healthcare professional. Learn how the patients of today and tomorrow are using technology as a key part of their healthcare and how you can be a bigger part of the Digital Patient Journey.
Strategies to improve linkage to HIV care aim to increase the percentage of people who enter care after receiving a positive HIV test result from 65% to 85%. Studies show those who enter care early are more likely to start antiretroviral therapy, achieve viral suppression, and reduce risky sexual behaviors. The document discusses various strategies tested in studies and used by agencies to improve different aspects of the linkage process, including messaging at diagnosis, counseling approaches, active versus passive referrals, engagement strategies, and care team coordination. The goal is to establish a seamless system to immediately link people to continuous, coordinated, and high-quality HIV care.
Antiretroviral Medication Adherence
The document summarizes evidence and recommendations for improving adherence to antiretroviral (ART) medication. It discusses how adherence is critical for treatment success and preventing HIV transmission. Current adherence levels tend to be suboptimal, around 50-60% on average. Key factors that influence adherence include treatment regimen complexity, mental health issues, social support, and the patient-provider relationship. The evidence shows that adherence interventions can effectively improve adherence when they address knowledge, barriers, medication management skills, and provide ongoing support. The recommendations focus on assessing and addressing individual patient barriers, simplifying treatment regimens, maintaining open communication, and involving adherence support teams.
Voice of the Empowered Patient: An Analysis of the Inspire Annual SurveyInspire
Inspire teamed with the trade organization Biotechnology Industry Organization for the seminar, “Connecting With the Empowered Patient in the Digital Age,” held Feb. 2015 at BIO headquarters in Washington, DC. The event brought together leaders from the patient advocacy community and life sciences industry to discuss how social media can be utilized to empower patients and engage advocates.
Inspire's Research Director Dave Taylor led the session, "Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey."
Factors that Influence Adherence to HAART - Naicker MHmichaela naicker
The document summarizes factors that influence adherence to highly active antiretroviral therapy (HAART) based on interviews with 13 HIV-positive individuals in South Africa. Key factors identified include: social support from family and friends which positively influences adherence; socioeconomic challenges like poverty, transportation costs, and unemployment which negatively impact adherence; and healthcare provider factors where public clinics raised privacy concerns but private providers offered more support and counseling. Disease symptoms and stigma also influence individual medication adherence. Overall, the study found social, economic, healthcare, personal, and treatment-related factors all play a role in levels of adherence.
This interactive webinar is part of the world tour series designed by the World Health Organization's Patients for Patient Safety (PFPS) Global Network and hosted by Patients for Patient Safety Canada, the patient-led program of the Canadian Patient Safety Institute, a WHO Collaborating Centre on Patient Safety and Patient Engagement.
This document provides information for HIV-positive Latinos on health, treatment, and living with HIV. It discusses how an HIV diagnosis can affect people emotionally and the importance of seeking support from community organizations. It also emphasizes the importance of self-care, continuing life goals and education, and accessing appropriate medical care and treatment options. The overall message is that while having HIV brings challenges, individuals are not alone and can take steps to maintain their health.
This document discusses nutritional considerations for people living with HIV/AIDS. It notes that while antiretroviral therapy can control the destruction of lean body tissue caused by HIV, some patients may experience fat accumulation, increased lipids, and insulin resistance after starting treatment. The document suggests following a diet high in fiber, proteins, and fats can help minimize metabolic disorders. It emphasizes choosing carbohydrates from whole, fiber-rich sources and combining carbohydrates with proteins, fiber and fats at meals to help control blood sugar and insulin levels. Maintaining the proper balance and sources of fats, proteins and carbohydrates is important for health, immune function and body composition for those living with HIV/AIDS.
This document provides information to support people who have recently tested positive for HIV. It covers topics such as understanding HIV and how it has changed since the 1980s/1990s, important health considerations after diagnosis like getting medical care and developing a relationship with one's doctor, health monitoring tests like CD4 count and viral load, general health tips, and resources for support. The overall message is that people can live well with HIV by getting informed, actively managing their health, and accessing available support services.
At the end of the session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to advance patient engagement in medication safety as a result of their increased understanding of:
. the role and responsibilities of patients/ families in medication safety
. different approaches to patient engagement in medication safety
. influencing factors (e.g. health literacy, culture, organizational and public policy)
. supporting resources and leading practices
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...iCAADEvents
There is little and con icting evidence on the prevalence of alcohol misuse and treatment available for people with Intellectual Disabilities (also referred as Learning Disabilities). As is similar to other vulnerable populations, adults with ID have increasingly lived more independently in the community following the closure of long-stay hospitals. This has increased their exposure to environmental stressors and substance and alcohol misuse, negatively impacting on their functioning, relationships, physical and mental health, and safety. Traumatic Brain Injury (TBI) is the most common cause of disability in younger adults. Yet the community care for patients with TBI varies hugely in the UK. There is a well-established link between TBI and alcohol misuse, with both TBI leading to increased levels of alcohol misuse and alcohol misuse contributing to risk of TBIs. The effects of neuronal damage have been shown to increase after TBI accompanied by alcohol intoxication.This presentation is based on the experience gained from the rst in the UK feasibility study on this topic, and draws from the experience of setting up and running the first ever pilot of a combined TBI and alcohol brief intervention service in London.
The document discusses using social media to understand patient journeys and identify opportunities to educate patients about a rheumatoid arthritis treatment called Product R. It describes analyzing social media posts to develop themes around patient barriers, milestones, and information needs at different stages, including treatment initiation, managing the condition, and becoming engaged in treatment. The analysis revealed opportunities to provide educational resources on side effects, problem solving strategies, and tools to facilitate patient-doctor communication.
This document summarizes a presentation on technologies to reduce prescription drug diversion, fraud, and abuse through electronic prescribing and drug deactivation systems. It discusses Delaware's pilot program with an at-home drug deactivation system. The presentation describes how electronic prescribing of controlled substances can reduce diversion and fraud while improving patient satisfaction. It also outlines DEA requirements for electronic prescribing and discusses Cambridge Health Alliance's experience implementing electronic prescribing of controlled substances with Epic and Imprivata. Finally, it summarizes the results of Delaware's pilot program, which provided at-home drug deactivation systems to specific pharmacies to promote safe disposal of unused prescription drugs.
How useful are advance directives in directing end of life care and do people really understand or want to know the true status of their health as the end nears?
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranOPUNITE
This document summarizes a presentation on a study examining how prescriber registration and use of a prescription drug monitoring program (PDMP) in Oregon impacted opioid prescribing patterns and patient outcomes. The study found that statewide opioid prescribing generally decreased over time, but prescribers who registered for the PDMP prescribed more after registering, especially those who used the PDMP most frequently. In contrast, prescribers who did not register prescribed less. Patients whose providers were all registered had lower overdose rates than those with some registered and some non-registered providers. The conclusions were that PDMPs may need refinements like mandatory use to optimize their impact on prescribing and outcomes.
The document discusses the Personal Health Record (PHR), which allows individuals to manage their own health information in order to better participate in their healthcare. A PHR contains health history, medications, allergies, immunizations and other medical data from individuals and providers. PHRs provide benefits like increased patient involvement, but also have barriers like usability, privacy and reliability concerns. The selection of a secure and standards-based PHR is important for managing personal health information.
Va open notes and blue button va ehealth university dec 2012Susan Woods
This document discusses the VA's Blue Button and Open Notes initiatives which aim to give patients access to their health records and information. It notes that over 1.9 million VA patients have registered for online access to their records through My HealtheVet. The document outlines what health data is currently available to patients through the VA's patient portal as well as what additional data may be made available in the future. It discusses the benefits of open notes and greater patient access to health records based on studies that have found it improves patient-provider communication, patient knowledge and self-care, and patient participation in their care. The document advocates for continued expansion of patient access to health records and greater patient involvement in healthcare design and delivery.
Nothing in our world is changing as quickly as healthcare. Patients are using search, social media and apps to diagnose symptoms, research physicians, schedule appointments, access medical records, connect with other patients and take a more active role in their health. At the same time the tremendous amount of data created by this activity means patients have a much larger digital footprint than ever before. Savvy healthcare marketers can use this data to attract new patients, improve care and collaborate with other healthcare professional. Learn how the patients of today and tomorrow are using technology as a key part of their healthcare and how you can be a bigger part of the Digital Patient Journey.
Strategies to improve linkage to HIV care aim to increase the percentage of people who enter care after receiving a positive HIV test result from 65% to 85%. Studies show those who enter care early are more likely to start antiretroviral therapy, achieve viral suppression, and reduce risky sexual behaviors. The document discusses various strategies tested in studies and used by agencies to improve different aspects of the linkage process, including messaging at diagnosis, counseling approaches, active versus passive referrals, engagement strategies, and care team coordination. The goal is to establish a seamless system to immediately link people to continuous, coordinated, and high-quality HIV care.
Antiretroviral Medication Adherence
The document summarizes evidence and recommendations for improving adherence to antiretroviral (ART) medication. It discusses how adherence is critical for treatment success and preventing HIV transmission. Current adherence levels tend to be suboptimal, around 50-60% on average. Key factors that influence adherence include treatment regimen complexity, mental health issues, social support, and the patient-provider relationship. The evidence shows that adherence interventions can effectively improve adherence when they address knowledge, barriers, medication management skills, and provide ongoing support. The recommendations focus on assessing and addressing individual patient barriers, simplifying treatment regimens, maintaining open communication, and involving adherence support teams.
Voice of the Empowered Patient: An Analysis of the Inspire Annual SurveyInspire
Inspire teamed with the trade organization Biotechnology Industry Organization for the seminar, “Connecting With the Empowered Patient in the Digital Age,” held Feb. 2015 at BIO headquarters in Washington, DC. The event brought together leaders from the patient advocacy community and life sciences industry to discuss how social media can be utilized to empower patients and engage advocates.
Inspire's Research Director Dave Taylor led the session, "Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey."
Factors that Influence Adherence to HAART - Naicker MHmichaela naicker
The document summarizes factors that influence adherence to highly active antiretroviral therapy (HAART) based on interviews with 13 HIV-positive individuals in South Africa. Key factors identified include: social support from family and friends which positively influences adherence; socioeconomic challenges like poverty, transportation costs, and unemployment which negatively impact adherence; and healthcare provider factors where public clinics raised privacy concerns but private providers offered more support and counseling. Disease symptoms and stigma also influence individual medication adherence. Overall, the study found social, economic, healthcare, personal, and treatment-related factors all play a role in levels of adherence.
This interactive webinar is part of the world tour series designed by the World Health Organization's Patients for Patient Safety (PFPS) Global Network and hosted by Patients for Patient Safety Canada, the patient-led program of the Canadian Patient Safety Institute, a WHO Collaborating Centre on Patient Safety and Patient Engagement.
This document provides information for HIV-positive Latinos on health, treatment, and living with HIV. It discusses how an HIV diagnosis can affect people emotionally and the importance of seeking support from community organizations. It also emphasizes the importance of self-care, continuing life goals and education, and accessing appropriate medical care and treatment options. The overall message is that while having HIV brings challenges, individuals are not alone and can take steps to maintain their health.
This document discusses nutritional considerations for people living with HIV/AIDS. It notes that while antiretroviral therapy can control the destruction of lean body tissue caused by HIV, some patients may experience fat accumulation, increased lipids, and insulin resistance after starting treatment. The document suggests following a diet high in fiber, proteins, and fats can help minimize metabolic disorders. It emphasizes choosing carbohydrates from whole, fiber-rich sources and combining carbohydrates with proteins, fiber and fats at meals to help control blood sugar and insulin levels. Maintaining the proper balance and sources of fats, proteins and carbohydrates is important for health, immune function and body composition for those living with HIV/AIDS.
This document provides information to support people who have recently tested positive for HIV. It covers topics such as understanding HIV and how it has changed since the 1980s/1990s, important health considerations after diagnosis like getting medical care and developing a relationship with one's doctor, health monitoring tests like CD4 count and viral load, general health tips, and resources for support. The overall message is that people can live well with HIV by getting informed, actively managing their health, and accessing available support services.
This document discusses potential issues with using herbs, vitamins, and supplements in people living with HIV. It notes that while complementary therapies are commonly used, many have not been well-studied in HIV patients and may interact negatively with antiretroviral drugs or have their own side effects. The document highlights some emerging concerns, such as supplements containing dangerous chemicals or prescription drugs. It emphasizes the importance of being cautious when combining supplements with antiretroviral therapies due to possible interactions and unknown risks or benefits.
This document provides an overview of dietary supplements and safety considerations for their use. It defines dietary supplements as products intended to supplement the diet that contain vitamins, minerals, herbs or other ingredients. While some supplements have proven health benefits, regulations are less strict than for drugs and more research is often needed. The document recommends consumers get information from healthcare providers and reliable sources before using supplements and to discuss any usage with providers.
This document discusses winter nutrition and foods that nourish kidney energy according to traditional Asian medicine. It recommends eating soups, stews, roasted and baked foods cooked in healthy fats to warm the body in winter. Foods like beans, seaweed, nuts and grains nourish the kidneys, while spices, citrus, meat and animal products boost kidney yang energy. Recipes for a stir fry and trail mix incorporating kidney-nourishing ingredients are also provided.
Tony Lane is the founder of Positive Life, an organization that empowers and supports people living with HIV through education, linkage to care, and community. The document discusses HIV/AIDS statistics in Fresno County, details about HIV transmission and treatment, the importance of disclosure and dating safely as an HIV positive individual, and resources available for support.
This document provides information about various components that may be analyzed in urinalysis, urine sediment, and other body fluids and samples. It discusses normal ranges and clinical significance of findings for numerous tests, including urinalysis dipstick components, microscopic examination of urine sediment, cerebrospinal fluid analysis, culture of various clinical samples, and numerous serological tests. The document is intended as a reference for clinicians on interpreting results from these diagnostic tests.
Makingdecisionsabouttherapies 110914180647 Phpapp02Positive Life
This document discusses considerations for developing a personal HIV treatment plan. It emphasizes:
1) Choosing an experienced HIV doctor who has treated many HIV patients and can provide informed guidance on treatment options.
2) Developing the right relationship with your doctor by discussing your decision-making style and becoming well-informed about HIV and various treatment strategies.
3) Talking to your doctor before starting any treatment to agree on monitoring plans and goals of therapy. Getting informed on your health condition and options from objective sources can empower you to make the best decisions.
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)Positive_Force
This document provides guidance on building a cooperative relationship between patients and doctors for HIV care. It suggests that patients should (1) share their point of view, learn as much information as possible, and prepare for appointments, while doctors should (2) support their patients' interests, be flexible in their responses, and describe issues from multiple sides. It also addresses how to handle disagreements, noting that changing doctors should only be a last resort when other options cannot establish an acceptable relationship.
Making Decisions About Therapies (Additional PLUS Reading Materials)Positive_Force
This document discusses considerations for developing a personal HIV treatment plan. It emphasizes the importance of choosing an experienced healthcare provider, getting informed about HIV and treatment options from credible sources, and having open discussions with your doctor. Key factors in deciding when to start treatment include CD4 count, viral load, symptoms, and personal readiness and commitment to therapy. Overall health and individual circumstances should guide treatment decisions.
Jim McManus is the Director of Public Health for Hertfordshire. The document discusses strategies to address vaccine hesitancy for the COVID-19 vaccine. It defines vaccine hesitancy and outlines approaches for building confidence in the vaccine, including providing accurate information, acknowledging concerns, and promoting peer influence and role models. Barriers to vaccine uptake are addressed at both the organizational and individual level.
This document provides tips for making better healthcare decisions by being an empowered patient. It advises patients to take ownership of their own medical records, focus on communicating openly with doctors to understand treatment plans and avoid errors, and prepare for doctor's visits by writing down concerns and previous treatments. Additional tips include improving communication between all caregivers, knowing personal health risks and taking preventive actions like screening tests and lifestyle changes like diet and exercise. The goal is for patients to gain knowledge to motivate positive health behaviors and feel empowered in their own care.
The document discusses using mobile apps and technology to create a more patient-centered healthcare system. It describes how apps can provide patients with healthcare information, facilitate communication between patients and providers, and help educate patients. Quality measures for healthcare can be improved by giving patients a more direct role in their care and accessing feedback through their app usage and behaviors. The document presents examples of potential apps, like one that helps asthma patients track their conditions and medications. Overall, the goal is to empower patients and turn them into active customers through mobile technologies.
The document discusses information therapy and the importance of empowering patients through education. It argues that patients should not leave all decisions up to doctors, but rather become informed partners through accessing reliable health information. The organization HELP provides various educational resources to patients and works with doctors, hospitals, and companies to promote information therapy and empowered patient decision making.
This document discusses the importance of health literacy and provides tips for improving health communications.
Health literacy is defined as a person's ability to obtain, process, and understand basic health information. Education level is the best predictor of health status, and those with low health literacy often have poor health outcomes. The document outlines strategies health lawyers can use to incorporate health literacy into their work, such as using clear language and design in documents and ensuring clients are trained to effectively communicate with patients. Tips for improving health communications include structuring all materials for low literacy, using universal precautions, emphasizing in-person conversations, employing user-focused design, and carefully explaining risks and statistics. An example process for creating a health-literate
End-of-life decision making is a delicate and often avoided undertaking. “Thinking Ahead: Conversations across California” is a project to learn from seniors and providers what worries them about end-of-life planning and decision making. One focus group participant said “I want to have a voice in deciding what the last few weeks of my life will be like. And, I want my wishes to be honored.” Read the short report to learn what is important to seniors.
Fix the Lack of Communication in Your PracticeJim Cucinotta
This document discusses the lack of communication between healthcare providers and patients. Most patients do not understand their conditions or treatment plans, and providers are not always good at explaining things clearly. As a result, patients may not understand risks or know how to manage their health. The document proposes that providers use a digital patient education platform to better inform patients at each stage of care through group education, individualized explanations, and ongoing engagement through email and social media. This platform tailors content from trusted sources to each practice in an affordable way that takes little time to implement.
Consumer Attitudes About Comparative EffectivenessMSL
Evidence as an essential—but insufficient—ingredient for medical decision-making. Presentation to the National Comparative Effectiveness Summit by Chuck Alston, SVP and Director of Public Affairs at MSLGROUP Washington, DC on September 16, 2013.
Senior access to health information nahsl.2011Tim Roberts
This document summarizes a project to teach senior citizens computer and internet skills to access health information online. The project partnered with a senior center to provide an 8-week computer training class onsite. 15 students consistently attended classes that covered basic computer use, email, evaluating health websites, and using specific resources like MedlinePlus. Challenges included temporary internet outages and addressing students with different languages. Evaluations found students learned skills and felt confident finding health information online. The project concluded that bringing educational resources directly to seniors was an effective way to teach internet skills and promote health information literacy.
Senior access to health information nahsl.2011Tim Roberts
This document summarizes a project to teach senior citizens computer and internet skills to access health information online. The project partnered with a senior center to provide an 8-week computer training class onsite. Classes covered basic computer use, email, evaluating health websites, and using specific resources like MedlinePlus. Having the class onsite and a low student-teacher ratio helped ensure students' individual needs were met. While there were challenges like temporary internet outages, most students reported learning skills and feeling more confident using the internet for health information after completing the course. The project concluded that bringing educational resources directly to seniors in their communities is an effective way to promote health literacy.
While utilizing solutions such as medical transcription services can be beneficial for doctors, they should also focus on fostering certain good qualities.
1. The document discusses how providing patients with information can empower them and improve their relationship with doctors. This approach is called "Information Therapy".
2. It argues that empowering patients with knowledge allows them to make better healthcare decisions in partnership with their doctors, take better care of themselves, and save money by avoiding overtreatment.
3. The organization HELP provides patients and doctors with educational materials, talks, and other resources to facilitate Information Therapy and improve communication between patients and doctors.
1. The document discusses how providing patients with information can empower them and improve their relationship with doctors. This concept is called "Information Therapy".
2. It describes how HELP (Health Education Library for People) provides patients with easy-to-understand educational materials across a wide range of health topics to help them make better healthcare decisions in partnership with their doctors.
3. The organization aims to grow its national network of patient education centers and resources in order to continue empowering more patients through Information Therapy.
PCPs serve as patients' first point of contact with the healthcare system. They are trained to treat a wide range of medical issues and coordinate care between specialists. PCPs prioritize preventative care through regular checkups and screenings to catch potential health problems early. When issues are outside their expertise, PCPs refer patients to specialists, maintaining communication to ensure coordinated care toward patients' health goals. Choosing the right PCP involves considering a provider's qualifications and ensuring a good fit with individual health needs and insurance coverage.
Complimentry and aternative medicine continuedPositive Life
The document discusses complementary and alternative medicine (CAM) and provides guidance on evaluating CAM therapies and practitioners. It advises that when considering CAM:
- Research the scientific evidence for safety and effectiveness before using a therapy
- Choose CAM practitioners carefully and discuss CAM use with healthcare providers
- Be aware that "natural" therapies can still have risks, and quality and ingredients vary
This document defines key terms related to complementary and alternative medicine (CAM). It explains that CAM refers to medical systems and practices that are not generally considered part of conventional medicine. The National Center for Complementary and Alternative Medicine (NCCAM) studies CAM therapies and categorizes them into whole medical systems, mind-body medicine, biologically based practices, manipulative and body-based practices, and energy medicine. NCCAM aims to research CAM scientifically and provide authoritative information to the public.
Women may experience different types or rates of side effects from HIV drugs than men, due to factors like differences in body weight, hormone levels, or how drugs are metabolized. Common side effects include fatigue, rash, neuropathy, diarrhea, dry mouth, headache, hair loss, and anemia. The document provides tips for managing each side effect, such as staying hydrated for diarrhea, using salves for rash, getting support from others, and asking a doctor about side effect risks before starting a new treatment.
Taking HIV medication requires strict adherence to a complex regimen of multiple daily pills and dietary restrictions. Staying adherent is challenging and many factors can interfere. It is important for patients to carefully consider their lifestyle, daily routines, support systems and any barriers to determine the best regimen and adherence strategies. This may involve trialing strategies like using pillboxes or alarms, integrating medications into daily habits, and planning for disruptions to routines. Building a strong relationship with medical providers and understanding the treatment plan is also key to maintaining adherence.
Consideringtreatmentandyourhealthcare 130129172100-phpapp01Positive Life
This document provides information to help people living with HIV consider when to start treatment. It discusses how treatment has improved over time, with fewer side effects and easier regimens. Starting treatment earlier is generally recommended to preserve immune function and prevent long-term health issues. Factors like CD4 count, viral load trends, general health, and readiness should be considered. Recommended first line regimens include combinations of antiretrovirals from different drug classes. Understanding test results can show how well treatment is working. Resistance testing before starting treatment can help identify the best regimen.
This document provides an overview of dietary supplements: it defines what dietary supplements are, discusses their regulation and safety considerations for use. Key points include that supplement manufacturers do not need to prove safety before marketing, and supplements can interact with medications. The document recommends consulting healthcare providers and reliable sources like the NIH for science-based information on supplements.
The document provides information for HIV-positive individuals on maintaining their health and treatment. It discusses the importance of being flexible with treatment decisions as one's life changes over time. It emphasizes making the most of medication and lab work by properly taking pills, understanding test results, and dealing with occasional missed doses or blips in viral load. The document stresses keeping up with healthcare by having stable insurance coverage and a consistent medication supply. It notes some may need to switch medications and addresses common concerns people may face at different stages of living with HIV.
The document summarizes key changes made in the January 10, 2011 update to the guidelines for use of antiretroviral agents in HIV-1-infected adults and adolescents. These include providing more flexible CD4 count monitoring, defining virologic failure as a viral load >200 copies/mL, adding specific recommendations for INSTI resistance testing and treatment of HBV/HIV coinfection, and earlier initiation of ART for those with active tuberculosis. The adverse effects, treatment goals, and drug characteristics tables were also updated.
This document provides information on sexually transmitted infections (STIs), including their causes, symptoms, and prevention. It discusses the main categories of bacterial and viral STIs such as chlamydia, gonorrhea, hepatitis A/B/C, herpes, HIV, human papillomavirus, and syphilis. Key points covered include how STIs can be transmitted and increase HIV risk, the importance of getting tested regularly, and strategies for prevention through condom and barrier use, partner communication, and limiting sexual partners. Resources for testing and treatment in San Francisco are also listed.
This document discusses winter nutrition and foods that nourish kidney energy according to traditional Chinese medicine. It recommends eating soups, stews, roasted and baked foods to warm the body in winter. Foods like beans, seaweed, grains and nuts nourish kidney yin and yang. It provides recipes for a stir fry, trail mix and bone broth that contain kidney-nourishing ingredients. It also discusses balancing oxidative stress and blood sugar to support healthy aging.
Hivtreatmentdecember2011 111204184012 Phpapp02Positive Life
1) HIV treatment involves taking a combination of antiretroviral drugs from different classes that target different stages of the HIV lifecycle.
2) Guidelines recommend starting treatment when a patient's CD4 count drops below 500 or if they have an AIDS-defining illness, though some experts argue for earlier treatment given potential benefits.
3) Common treatment regimens involve two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) as the "backbone" plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI). The goals are to suppress viral load, increase CD4 count, and prevent disease progression.
The document discusses the life cycle of HIV and the stages of HIV disease progression if left untreated. It describes the five stages of the HIV life cycle: (1) entry, (2) reverse transcription, (3) integration, (4) transcription, and (5) maturation. It also includes timelines of drug development and the typical course of untreated HIV disease progression from initial infection to AIDS.
Dealingwithsideeffects 110914180652 Phpapp02Positive Life
The document discusses common side effects from HIV medications and provides tips for managing them. It covers fatigue, rash, diarrhea, dry mouth, headache, anemia, nausea, vomiting, weight loss, and period problems. For each side effect, it explains causes and symptoms, and provides simple lifestyle steps and remedies to help cope with and potentially reduce the side effects. The key message is that while side effects vary, talking to one's doctor and adopting self-care strategies can help improve quality of life when taking HIV drugs.
This document discusses self-advocacy and its importance for people living with HIV/AIDS. It traces the roots of self-advocacy to the civil rights movement for people with disabilities. Self-advocacy refers to people with disabilities taking control of their own lives and medical decisions. The document also discusses self-efficacy, assertiveness, methods of self-advocacy, and examples of HIV/AIDS advocacy organizations in San Francisco like Project Inform and Project Open Hand that provide resources and empower those living with HIV/AIDS. Access to information and social support networks allows greater self-advocacy, assertiveness and efficacy.
The document provides information and strategies for improving adherence to HIV medication regimens. It discusses how taking multiple pills daily can be challenging. It suggests considering one's readiness and ability to commit to treatment demands before starting. Proper adherence involves taking the full dose as prescribed with any food or other restrictions. The document outlines factors to consider in choosing an appropriate regimen and offers planning strategies like using daily routines and pill organizers to integrate medications into one's lifestyle. Building support networks can also help with adherence.
This document provides 12 steps for improving nutrition over the course of a year. The steps include using unrefined salt and avoiding refined salt, focusing on healthy fats like butter and olive oil while eliminating unhealthy fats, improving the quality of animal proteins, making bone broth from saved bones, eating local seasonal produce, choosing whole grains over refined carbs, reducing processed foods, choosing natural sweeteners over sugar, minimizing caffeinated drinks, eating fermented foods with meals, saving money by avoiding supplements, and avoiding toxins.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
2. TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
2
the basis for making decisions
Regardless of the therapy you consider, the same basic
principals for making decisions can be used, including:
CHOOSE AN EXPERIENCED PROVIDER.
Choose a healthcare provider or doctor
who is experienced with the treatment of
HIV disease and with the types of therapy
you are interested in pursuing.
DEVELOP THE RIGHT RELATIONSHIP.
Learn about the different types of doctor/
patient relationships; determine how you
want to interact with your doctor and
develop the right relationship. Discuss
your decision-making process style of
relationship with your healthcare provider.
GET INFORMED! Learn about your
health condition(s) and possible treatment
options:
sources of information that give you objective information about various treatments
and strategies. Project Inform offers this kind of information free-of-charge through
a toll-free hotline, printed documents, public meetings and website.
TALK BEFORE YOU START. Talk to your doctor before you start therapy
(regardless of what that therapy is) and come to mutual agreements about:
4. TOLL-FREE NATIONAL HIV/AIDS TREATMENT INFORMATION HOTLINE 1-800-822-7422 LOCAL/INTERNATIONAL 415-558-9051 MONDAY-FRIDAY 9-5 SATURDAY 10-4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
4
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
A key to participating in treatment decision making is to get informed about
HIV disease, treatment options and overall strategies sooner rather than later.
If a person waits too long before seeking medical care and has already come down
with an opportunistic infection, there may be little time to learn about options since
immediate treatment may be needed.
Whenever possible, people should get informed about treatment strategies and
option well before it’s time to start treatment.For more information about monitoring
HIV disease, call Project Inform’s Hotline and ask for Day One.
If you’re healthy and not feeling like you need or want to start therapy immediately, it’s
still a good idea to learn about your treatment options and strategies and begin talking
with your doctor about what to do and when to do it. Making those decisions before the problem is critical can
diminish some of the fear that is often associated with starting any kind of therapy for the first time. Starting these
discussions with your doctor is perhaps the best form of “early intervention” and will greatly increase the chances
that you will avoid starting therapy either too early or too late.
What does the research show?
Getting informed and learning about HIV and your options
and strategies may seem overwhelming at first. It’s not easy
for anyone. Sometimes it’s hard to read about HIV disease
and the information may sometimes seem like it’s written in
a foreign language ... at first!
One of the missions ofProject Inform is to provide under-
standable information to people living with HIV. The staff
at Project Inform spends hundreds of hours annually in
medical libraries, attending medical conferences and ana-
lyzing studies to learn about the latest advances and what
they mean. We try our best to put that information together
in a way that people who aren’t scientists or doctors can
understand it.
Some people think of Project Inform as a sort of Consumer
Reports on HIV treatments. Though we do everything we can
to make it the best source, Project Inform is not the only
place to get information about HIV treatments and strate-
gies, however. There are several newsletters and sources of
HIV information, each with its own special benefits.
For a list of references, call Project Inform’s Hotline and
ask for Guide to HIV/AIDS Related Resources. The Project
Inform Hotline operates Monday through Friday and vol-
-
tions you might have and mail you information, free of charge.
Explore, examine and challenge
your beliefs about therapy.
Most people have concerns and fears about starting therapies,
be they anti-HIV therapies or complementary herbal ther-
apies. Learning about that therapy can sometimes lessen
your concerns and help you decide whether it’s right for you.
Consider how it might impact your lifestyle and whether any
dietary restrictions may be a problem. Learn about poten-
tial side effects and prepare for them, should they occur.
In exploring your beliefs about a therapy, you might find
that you have come to a conclusion based on personal fears
or rumors. Grounding yourself in knowledge, rather than
fears, and challenging where possibly unfounded beliefs might
be clouding decision-making is critical. Challenging your
beliefs and seeking their roots is important. Personal experi-
ence and knowledge about a given therapy is far better infor-
mation to inform decision-making than fears or conjecture.
With that said, however, if you truly believe that a parti-
cular approach may be more harmful to you than its poten-
tial benefits, you might be better off considering another
option. You can always revisit that decision at a later time.
Don’t reject what you believe about therapy when it comes
to making your decision—it should weigh in with other
considerations but those beliefs should be explored, exam-
ined and challenged.
Get informed!
Learn about HIV disease and ...
6. TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
6
When to start?
Starting any ther-
apy can cause anxi-
ety. There is no one
proven “right” time to
start anti-HIV therapy,
for example, for everyone.
There are differing opinions about
starting therapy early in the course of
HIV infection vs. later. Either choice
In general, current thinking in the
US and Europe is leaning in favor of
delaying treatment until there has been a
significant decline on CD4+ cell counts.
The most recent research shows that
this loss can usually be recovered when
people start treatment.
In contrast, starting treatment very
early, before significant decline of CD4+
cell counts, can force people to begin
using up the limited time that each
drug will work, earlier than necessary.
It may also lead to an earlier risk of
developing both drug side effects and
drug resistance. These cannot always be
corrected so easily. (For more informa-
tion, call Project Inform’s Hotline and
ask for Anti-HIV Therapy Strategies).
While there are instances where
using anti-HIV therapies have clearly
been shown to be beneficial, when to
start therapy remains an individual
decision. Most important, it doesn’t
make sense to start therapy until you
are ready and committed to it.
Making a decision about what cri-
teria you will use as a basis for starting
therapy (of any kind, anti-HIV therapy,
herbal therapy, etc.) puts the decision
and control over using therapy in your
hands. Making decisions about com-
plementary therapies are often more
difficult and complex because there’s
a lack of information from studies to
help guide decision-making. (Read
Project Inform’s publication entitled
Herbs, Supplements and HIV.)
For example, you might decide
to start an herbal therapy right now,
regardless of your CD4+ cell count,
your viral load and your overall gen-
eral health. Or, you might decide to
start anti-HIV therapy if your CD4+
cell count has a decreasing trend to
below 350 and/or your viral load con-
tinues to rise above 50,000 and/or you
begin to experience symptoms associ-
ated with HIV disease. Deciding on
your own criteria, with the guidance
of your doctor, lets you be in control
of your treatment decisions.
How to monitor whether
therapy is working for you?
Before you start any kind of therapy, it’s
important to have realistic expectations
around what the therapy will do and
to determine how you will monitor to
decide if it is working. In terms of anti-
HIV therapy, typically you will look for
decreases in viral levels (HIV RNA),
increases in measure of immune health
(CD4+ cell counts) and improvements
in your overall general health.
Determining whether a complement-
ary therapy is working, when it doesn’t
have any direct anti-HIV activity, can
be difficult. How will you decide if that
you determine if it’s worth your money
(Remember, just because something is
available over-the-counter doesn’t mean
that there are no risks associated with
using it!)
choosing the best time to start
The following factors can help you and your provider
when choosing the best time for YOU to start therapy:
CD4+ TREND CD4+ cell count trends (consistently decreasing
CD4+ cell counts, over time, indicate immune health is declining);
the most recent guidelines suggest that anti-HIV treatment should
be encouraged when the counts fall consistently below 350 (some
guidelines recommend waiting until 200);
VIRAL LOAD TREND Trends in viral load (consistently increasing
HIV RNA levels, overtime, indicate that the virus is becoming more
active; this may either cause more damage to the immune system or
might be a signal that the immune system is failing already);
GENERAL HEALTH Overall general health and the presence or
absence of minor symptoms; and
YOUR READINESS TO START: You should begin treatment when
you’re ready for the demands of treatment. Without a strong basic
commitment, you’re likely develop poor adherence to your therapy.
Once you’ve made a
treatment decision, consider …
8. some final words on making decisions
For most people, the idea of having a decision-
making process around healthcare is a new concept.
The vast majority of us have done as we we’re told
when it comes to healthcare decisions. If the doctor
prescribed a pill, we simply took it. (Or we didn’t,
but we probably didn’t tell the doctor!)
Participating with your doctor—in choosing
therapies and monitoring for side effects and the
effectiveness of a therapy—is a new experience for
most people. It’s not something that all doctors feel
comfortable with nor is it something that many
people immediately feel comfortable with either.
Studies have shown, however, that people who
participate in their healthcare decisions and form a
partnership with an HIV-experienced doctor, tend
to do better.
While information about HIV and the various
options for managing HIV disease can at times
seem overwhelming, developing a decision-making
process around treatment is not a mystery. In fact,
the general principals of decision-making around
your health and treatment choices are the same
principals that you probably already apply in many
areas of your life.
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
8
In essence,
Once you’ve decided what you want to do, next decide:
for benefit), and
Moreover, plan ahead:
This type of decision-making process can be
applied to any kind of therapy approach, be it
pharmaceutical drugs, complementary therapy or
alternative systems of healing. Participating as a
full partner in your treatment decisions offers many
benefits, but it also takes effort on your part. The
likelihood of benefiting from therapy increases and
the likelihood of experiencing serious side effects
from therapy decreases when you’re involved in
decision-making and monitoring.